| Dr Brian Steven Philip, MD | |
|
255 Lafayette Ave, Suffern, NY 10901-4812 | |
| (845) 368-5000 | |
| (845) 357-5777 |
| Full Name | Dr Brian Steven Philip |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 18 Years |
| Location | 255 Lafayette Ave, Suffern, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083889174 | NPI | - | NPPES |
| 03259607 | Medicaid | NY | |
| P00974426 | Other | NY | RR MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 249080 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bay Anesthesia | 0446639306 | 29 |
| Ramapo Anesthesiologists, Pc | 3476444373 | 73 |
| Bay Anesthesia | 0446639306 | 29 |
News Archive
A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.
The early stages of embryonic development shape our cells and tissues for life. It is during this time that our newly formed cells are transformed into heart, skin, nerve or other cell types. Scientists are finding that this process is largely controlled not by the genome, but by the epigenome, chemical markers on DNA that tell cells when to turn genes on and off.
To coincide with Skin Cancer Awareness Month, the AVEENO Brand announces its third-year partnership with The Skin Cancer Foundation for the Road to Healthy Skin Tour, a program that has been instrumental in educating people nationwide about skin cancer detection and prevention. This year, the Tour will visit over 80 locations through September.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.
CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.
› Verified 8 days ago
| Entity Name | Ramapo Anesthesiologists, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235151002 PECOS PAC ID: 3476444373 Enrollment ID: O20040322000677 |
News Archive
A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.
The early stages of embryonic development shape our cells and tissues for life. It is during this time that our newly formed cells are transformed into heart, skin, nerve or other cell types. Scientists are finding that this process is largely controlled not by the genome, but by the epigenome, chemical markers on DNA that tell cells when to turn genes on and off.
To coincide with Skin Cancer Awareness Month, the AVEENO Brand announces its third-year partnership with The Skin Cancer Foundation for the Road to Healthy Skin Tour, a program that has been instrumental in educating people nationwide about skin cancer detection and prevention. This year, the Tour will visit over 80 locations through September.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.
CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.
› Verified 8 days ago
| Entity Name | Bay Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063151546 PECOS PAC ID: 0446639306 Enrollment ID: O20221227000592 |
News Archive
A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.
The early stages of embryonic development shape our cells and tissues for life. It is during this time that our newly formed cells are transformed into heart, skin, nerve or other cell types. Scientists are finding that this process is largely controlled not by the genome, but by the epigenome, chemical markers on DNA that tell cells when to turn genes on and off.
To coincide with Skin Cancer Awareness Month, the AVEENO Brand announces its third-year partnership with The Skin Cancer Foundation for the Road to Healthy Skin Tour, a program that has been instrumental in educating people nationwide about skin cancer detection and prevention. This year, the Tour will visit over 80 locations through September.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.
CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Steven Philip, MD 100 Route 59, Suite 105, Suffern, NY 10901-4927 Ph: (845) 357-5775 | Dr Brian Steven Philip, MD 255 Lafayette Ave, Suffern, NY 10901-4812 Ph: (845) 368-5000 |
News Archive
A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.
The early stages of embryonic development shape our cells and tissues for life. It is during this time that our newly formed cells are transformed into heart, skin, nerve or other cell types. Scientists are finding that this process is largely controlled not by the genome, but by the epigenome, chemical markers on DNA that tell cells when to turn genes on and off.
To coincide with Skin Cancer Awareness Month, the AVEENO Brand announces its third-year partnership with The Skin Cancer Foundation for the Road to Healthy Skin Tour, a program that has been instrumental in educating people nationwide about skin cancer detection and prevention. This year, the Tour will visit over 80 locations through September.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.
CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.
› Verified 8 days ago
Kareem Eltaki Eltaki, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5000 Fax: 845-357-5777 | |
Dr. Jane K Kim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Good Samaritan Hospital, Suffern, NY 10901 Phone: 845-368-5000 Fax: 845-357-5777 | |
Stephanie Moura, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-357-5775 Fax: 845-357-5777 | |
Dr. Bernard Baez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5039 Fax: 845-357-5777 | |
Tracey Jay Krzanowski, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Route 59, Suite 105, Suffern, NY 10901 Phone: 845-357-5775 Fax: 845-357-5777 | |
Miss Jennifer Narciso Alt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5039 Fax: 845-368-5327 |